Detalhe da pesquisa
1.
LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors.
Clin Cancer Res;
27(7): 2061-2073, 2021 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33355204
2.
Glucose-regulated insulin production from genetically engineered human non-beta cells.
Life Sci;
81(17-18): 1346-54, 2007 Oct 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17920636
3.
BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity.
Mol Cancer Res;
15(10): 1431-1444, 2017 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28655712
4.
csf1 is required for early embryonic macrophage development: characterization of the csf1(op)/csf1(op) mutation in ES cell-derived macrophages.
Br J Haematol;
141(5): 739-42, 2008 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18422785
5.
Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division.
Blood;
99(7): 2397-407, 2002 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11895772